All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
State angst over the murky realm of ever-increasing U.S. drug prices has moved from rhetoric to action, with Vermont leading the charge on requiring more transparency from biopharma.